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The kidney is an important organ for controlling the volume of body fluids, electrolytic balance and 
excretion/reabsorption of endogenous and exogenous compounds. Among these renal functions, excre-
tion/reabsorption of endogenous and exogenous substance is very important for the maintenance of 
physiological homeostasis in the body. Recently discovered organic anion transporters (OAT or SLC22A) 
have important roles for renal functions. It is well known as drug transporter. Several isoforms belong 
to SLC22A family. They showed different transport substrate spectrums and different localizations within 
the kidney. Their gene expressions are changed by some stimulus. The functional transport properties 
are regulated by protein kinase C. In addition, the function of organic anion transporters are also regulated 
by protein-protein interaction, such as caveolin which is compositional protein of caveolae structure. In 
this review, we will give an introduction of organic anion transporters and its regulatory mechanisms. 
Key Words:Kidney, Organic anion, Multispecific organic anion transporter, Tubular secretion, 
Xenobiotics, Renal localization, Caveolin
2)
Introduction
The kidney, as well as the liver, plays a primary role 
in the excretion of endogenous/exogenous compounds 
and their metabolites1-5). In addition to glomerular 
filtration, the kidney excretes charged compounds via 
carrier-mediated pathways, which are organic anion 
transport pathways, in renal proximal tubular cells6-9). 
Particularly the organic anion transport pathway has 
been shown to mediate the elimination of various drugs 
including anti-human immunodeficiency virus thera-
peutics, non-steroidal anti-inflammatory drugs, 
antitumor drugs, antibiotics, diuretics, and antihyper-
tensives
10). These compounds are chemically hetero-
geneous substances possessing a carbon backbone and 
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a net negative or positive charge at physiological pH. A 
great variety of endogenous and exogenous substances 
that are harmful to the body can be classified into 
organic anions, and their elimination is therefore 
essential for the maintenance of homeostasis. Excre-
tory organs such as the kidney, liver and intestine 
defend the body against potentially harmful effects of 
these compounds by biotransformation into less active 
metabolites and the excretory transport process. 
Particularly in the kidney, drugs and environmental 
toxicants are eventually excreted into the urine, either 
in the unchanged form or as biotransformation products. 
This renal excretion is closely related to physiological 
events occurring in nephrons, i.e., filtration, secretion, 
and reabsorption. 
More than 80 years ago, it was already observed that 
phenolsulfonphthalein, an organic anion, was highly 
concentrated in the renal convoluted tubules, indicative 
of the tubular secretion process11). Transepithelial 
transport of organic anions in proximal tubules is 
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Fig. 1. Amino acid sequence and membrane topology 
of rat organic anion transporter 1. OATs  show both 
N-terminus and C-terminus in intracellular site.
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carried out by two distinct transporters; first, organic 
anions are transported from the blood by basolateral 
organic anion transporter(s), and subsequently 
effluxed into the tubular lumen by luminal transporter 
(s). Until early 1990s, renal organic anion transport 
has been considered to be carried out by several 
carrier proteins that show wide substrate specificity. 
Various anionic compounds have been indicated to be 
taken up into the proximal tubular cells by the “classical 
PAH (p-aminohippurate) transporter”. Recently, 
several organic anion transporters were reported from 
the kidney, liver, and olfactory mucosa10, 12, 13). In 
addition, there are carrier proteins to transport organic 
anions such as organic anion transporting protein, multi 
drug resistance protein or p-glycoprotein, and so on. 
Therefore, in order to help reader’s comprehension, 
this review will focus on the present knowledge of 
molecular properties of renal organic anion 
transporters (OAT, SLC22A).
Molecular structure of organic anion transporter
In 1997, Sekine and Sweet et al. independently 
isolated the PAH transporter protein from rat kidney 
(OAT1/ROAT1) employing the expressional cloning 
technique10, 14). OAT1 and ROAT1 are identical and 
will be collectively referred to as OAT1. OAT1 is a 
551-amino-acid protein with 12 putative transmem-
brane domains (Fig. 1). Other members of OAT have 
535-568 amino acid residues and also have 12 mem-
brane spanning domains. The molecular structure of 
OAT1 has no similarity with those of other members of 
polyspecific organic anion transporter families, e.g., 
the organic anion transporting polypeptide (oatp) or 
the multidrug resistance-associated protein (Mrp) 
families. The amino acid sequence alignment of OATs 
shows that they have relatively high homology from 
36% to 50% (Table 1).
The all members of the OAT family have several 
protein kinase C (PKC) sites in predicted large loops 
between the sixth and seventh membrane spanning 
domains (Fig. 1). The transport function of OAT1, 
OAT3 and OAT4 is regulated by PKC. The PAH 
transport by rOAT115) and hOAT1
16) expressed in 
Xenopus laevis oocytes and in HeLa cells, respectively, 
was inhibited after treatment of cells with phorbol 
esters. This phorbol-ester-induced inhibition of PAH 
transport was prevented by staurosporin, suggesting 
an inhibitory role of protein kinase C in OAT1. The 
uptake functions of [3H] estrone sulfate or [
3H] dehy-
droepiandrosterone sulfate by OAT3 and OAT4 in 
overexpressed S2 cells or BeWo cells were also atte-
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Fig. 2. Mechanisms of organic anion transport in renal 
tubular epithelial cells. Transepithelial movement of 
organic anions across basolateral or apical membrane 
is mediated by OATs.
nuated by the existence of phorbol-ester, a protein 
kinase C activator17, 18). In addition, the putative pho-
sphorylation sites for protein kinase A, casein knase II, 
and tyrosine kinase have also been reported. Whether 
any of these sites is used for the regulation of OATs is 
as yet unclarified.
All OATs have several N-glycosylation sites 
between the first and second transmembrane domains. 
Inhibition of glycosylation by tunicamycin in mouse 
OAT1-expressing COS-7 cells resulted in an increase 
of intracellular accumulation of newly synthesized 
transporters, suggesting that glycosylation is required 
for insertion of OAT1 into the plasma membrane19).
Functional characteristics of 
organic anion transporter
A number of endogenous and exogenous organic 
anions are secreted in the renal proximal tubules. The 
active transepithelial secretion of organic anions into 
the urine is mediated by two types of transporter 
proteins existing in the basolateral and luminal mem-
branes of the renal proximal tubules. The first step is 
the uptake. Tubular secretion of organic anions occurs 
in two transmembrane transport processes (Fig. 2). 
When considering the electrical potential inside a cell of 
the proximal tubule, the basolateral uptake of organic 
anions is an uphill transport process. In 1987, Shimada 
and coworkers reported that uptake of para- 
aminohippuric acid (PAH), a typical substrate of renal 
organic anion transport system, was dramatically en-
hanced in the presence of an outward α-ketoglutarate 
gradient20). The PAH is taken up by proximal tubule 
cells in exchange for intracellular dicarboxylates, that 
are then returned to the cells via the Na＋- 
dicarboxylate cotransporter. These findings indicate 
that the PAH transporter is a tertiary active trans-
porter. Na＋, K＋ ATPase (a primary active transporter) 
generates the sodium ion gradient between the plasma 
membrane21), and the electrochemical gradient of the 
sodium ions derives the transport of dicarboxylates via 
the Na＋-dicarboxylate cotransporter (a secondary ac-
tive transporter)22). Using the gradient of dicarboxy-
lates, the PAH transporter takes up organic anions in 
exchange for the dicarboxylates (a tertiary active 
transporter). In addition to this classical PAH trans-
porter, an additional uptake system has been charac-
terized employing bulky organic anion fluorescein- 
methotrexate as a substrate23). Uptake of fluorescein- 
methotrexate is independent of Na＋ and is not inhi-
bited by PAH or glutarate. The molecular identity of 
this transporter has not yet been established. 
Molecular identification and 
tissue distribution of OATs
1. OAT1
The transport properties of OAT1 has been charac-
terized functionally using Xenopus oocytes and the cell 
expression system (Table 2). The cloned OAT1 has 
been expressed in Xenopus laevis oocytes10, 14-16,
24-26), COS-7 cells19), or HeLa cells
16). The uptake ratio 
of radiolabeled PAH in cells expressing these carriers 
was increased compared with that water-injected 
oocytes or mock-transfected cells, respectively. The 
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Table 2. Molecular Characteristics of Organic Anion Transporters in the Kidney
Trnasporter
(HGNC name)
Species
Asseccion
Number
Tissue 
distribution
Substrates
OAT1 (SLC22A6)
OAT2 (SLC22A7)
OAT3 (SLC22a8)
OAT4 (SLC22a11)
OAT5 (SLC22a19)
OAT6 (SLC22a20)
Human
Rat
Mouse
Human
Rat
Mouse
Human
Rat
Mouse
Human
Rat
Mouse
Mouse
AB009697
AB004559
U52842
AF097518
L27651
AF097491
AB017466
BC022387
AB026198
AI058341
BC021384
BC046588
kidney, brain
kidney, brain
kidney, brain
kidney, liver
kidney, liver, 
brain, eye
kidney, liver
kidney, placenta
kidney
olfactory mucosa
PAH, α-KG, cAMP, various anionic drugs
α-KG, salicylate, PAH, dicarboxylate
PAH, ochratoxin A, estrone sulfate, cimetidine
Estrone sulfate, dehydroepiandrosteon sulfate, ochratoxin A
Estrone sulfate, dehydroepiandrosteon sulfate, ochratoxin A
Estrone sulfate
HGNC : HUGO Gene Nomenclature Committee
reported Km values range between 5 and 70 µM (5 and 
9 µM for hOAT116, 25); 37 µM for mOAT1
19); 14 and 70 
µM for rOAT110, 14) and 21 µM for flounder OAT1
27)). 
Uptake of PAH by rOAT1, hOAT1, and fOAT1 was 
trans-stimulated by intracellulary accumulated α- 
ketoglutarate or glutarate. Similarly, efflux of radio-
labeled glutarate from OAT1-expressing oocytes was 
trans-stimulated by PAH in the incubation medium28). 
It was proved that OAT1 acts as a PAH/ dicarboxylate 
antiporter. In addition to PAH, rOAT1 mediated the 
transport of various organic anions, including endo-
genous organic anions, such as prostaglandin E2 
(PGE2), cyclic guanosine monophosphate (cGMP), 
cyclic adenosine monophosphate (cAMP), dicarboxylic 
acid and urate, and exogenous ones, including a number 
of anionic drugs such as β-lactams, nonsteroidal 
antiinflammatory drugs (NSAIDs), antiviral drugs, and 
methotrexate10, 15, 28-31). The affinities of these com-
pounds for OAT1 were very similar to those reported 
for those of the basolateral PAH transporter. In 
addition, the hydrophobicity and the strength of the 
anionic charge of substrates appear to be closely 
related to their affinity for OAT1
32). OAT1 also 
transports ochratoxin A33) that is well known as the 
etiologic agent responsible for Balkan nephropathy. 
When OAT1-overexpressing cells and mock-trans-
fected cells were exposed to ochratoxin A, decreased 
cell viability was observed in OAT1-expressing cells, 
which were recovered by inhibition of the OAT1- 
mediated uptake of ochratoxin A. This result suggests 
that OAT1 is associated with proximal tubular damage 
caused by anionic toxicants33, 34).
Recently, an electrophysiological approach was used 
to demonstrate translocation of organic anions by 
fOAT1-expressing Xenopus oocytes35). PAH, etacry-
nic acid, bumetanide, and tienilic acid evoked an inward 
current. In contrast to these compounds, probenecid 
and furosemide did not generate an inward current.
The tissue distribution of cloned rat, mouse, and 
human OAT1 is investigated by northern blot analysis 
(Table 2)10, 14-16, 19, 25, 26). rOAT1, mOAT1, and hOAT1 
mRNAs are expressed predominantly in the kidney and 
very weakly in the brain. In the rat kidney, rOAT1 is 
localized in the middle portion of proximal tubules (S2 
segment) as determined by in situ hybridization
10). 
Immunohistochemical localization also demonstrated 
the rat36, 37) and human OAT1
25) proteins are restricted 
to the S2 segment of proximal tubular cells. Western 
blot analysis revealed that the rOAT1- encoded 
protein size was about 77 kDa. This rOAT1 protein was 
up-regulated by infusion of chronic furoemide or 
hydrochlorothiazide38).
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2. OAT2
OAT2 has cloned by the membrane protein pre-
viously called the novel liver transporter (NLT), but 
whose transport substrates had not been identified39). 
Rat OAT2 had 42% amino acid sequence homology with 
rOAT1, and was shown to be a member of the OAT 
family (Table 1)40). rOAT2 mediated the sodium- 
independent transport of salicylate (Km=88 µM) and  α
-ketoglutarate (Km=18 µM). rOAT2 also mediated the 
transport of PGE2, methotrexate, acetylsalicylate, and 
PAH (Table 2). rOAT2 is a 535-amino-acid protein 
with 12 putative membrane- spanning domains. rOAT2 
mRNA is predominantly expressed in the liver, and 
weakly in the kidney. Immunohistochemical lo-
calization also demonstrated the rat OAT2 protein is 
detected in the apical surface of the tubule in the 
medullary thick ascending limb of Henle’s loop and 
cortical and medullary collecting ducts. Western blot 
analysis revealed that the rOAT2-encoded protein 
size was about 60 kDa41). Mouse OAT2 was isolated 
and characterized in 200242). Different from rOAT2, 
mOAT2 is 540-amino-acid protein having 88% 
homology with rOAT2. Gene expression of mOAT2 
was quite different from that of rOAT2. In contrast to 
rOAT2 mRNA was expressed predominantly in liver, 
mOAT2 mRNA was not detected in liver with Northern 
blot analysis. This mOAT2 mRNA was weakly detected 
in female liver but not kidney. In substrate specificity, 
mOAT2 mediated the sodium-independent transport 
of glutarate (Km=15.8 µM) and PGE2 (Km=5.2 µM). 
Interestingly, no transport of salicylate, prototype sub-
strate of rOAT2, was detected. The gene expression of 
rOAT2 in isolated hepatocytes were down-regulated 
by the treatment with nitric oxide43).
3. OAT3
Rat OAT3, another member of the multispecific 
organic anion transporter family, was isolated from the 
rat brain by the RT-PCR cloning method based on the 
sequence conserved among rOAT1, rOAT2, rOAT5 
and mOAT644).
rOAT3 shows 49, 39, 37 and 48% identity with 
rOAT1, rOAT2, rOAT5 and mOAT6, respectively 
(Table 1). When expressed in Xenopus oocytes, 
rOAT3 mediated the uptake of organic anions such as 
estrone sulfate (Km=2.3 µM), ochratoxin A (Km=0.74 
µM), and PAH (Km=65 µM), and cimetidine (Table 2). 
OAT3 also interacted with anionic neurotransmitter 
metabolites, such as epinephrine, norepinephrine, and 
serotonin. The transport mode of OAT3 was sodium- 
independent, and no trans-stimulatory effect of 
estrone sulfate, PAH, or ochratoxin A was detected in 
used Xenopus oocyte expression system. When rOAT3 
is expressed in cells, rOAT3-mediated estrone sulfate 
uptake is enhanced compared with that in the case of 
mock-transfected cells. When cRNA injected Xenopus 
oocyte or renal slice were preloaed with dicarboxylate, 
the transport of substrate mediated rOAT3 was en-
hanced. This fact shows that rOAT3 is also exchanger 
protein45). In 1999, Race et al. reported hOAT3
26). 
They failed to detect any functional properties of 
hOAT3. Cha et al. also reported hOAT3 in 200146). This 
newly cloned hOAT3 transported estrone sulfate 
(Km=3.2 µM), PAH (Km=87.2 µM), methotrexate 
(Km=10.9 µM), cimetidine (Km=57.4 µM), dehydro-
epiandrosterone sulfate, estradiol glucuronide, gluta-
rate, PGE2 and so on. The difference of these two clone 
was that the amino acid sequences of C-terminus of 
newly identified hOAT3 was shorter than those of old 
hOAT3. rOAT3 mRNA was expressed in the liver, 
kidney and brain, and a weak expression was detected 
in the eye. hOAT3 mRNA was detected mainly in the 
kidney and very weakly in the brain and smooth muscle. 
The distribution of hOAT3 protein was observed at the 
basolateral membrane of proximal tubule cells
4. OAT4
Recently, we identified the fourth member of organic 
anion transporter expressed in the human placenta 
using EST (expressed sequence tag) database 
searched for “query OAT1”
47). OAT4 is a 551- 
WY Lee, et al. : Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins  13
Fig. 3. The structure of caveolae in plasmamembrane. 
The small flask shapes indicated by arrow were 
caveolae (from Vol. 46: H2222, Am J Physiol, 1999). 
Bar, 120 nm.
amino-acid protein with 12 putative membrane- 
spanning domains. hOAT4 showed 38 to 44% identity 
with those of other members of the OAT family (Table 
1). When expressed in Xenopus oocytes, OAT4 
mediated the high-affinity transport of estrone sulfate 
(Km=1.01 µM) and dehydroepiandrosterone sulfate 
(Km=0.63 µM) in a sodium-independent manner 
(Table 2). OAT4 also mediated the transport of 
ochratoxin A and PAH. OAT4- mediated transport of 
estrone sulfate was inhibited by several sulfate 
conjugates, such as p-nitrophenyl sulfate, α-naphthyl 
sulfate, β-estradiol sulfate, and 4- methylumbelliferyl 
sulfate. In contrast, glucuronide conjugate showed little 
or no inhibitory effect on the OAT4-mediated transport 
of estrone sulfate. Recent report has shown that the 
transport mode of hOAT4 was also organic anion/ 
dicarboxylate exchagner48). Northern blot analysis 
revealed that OAT4 mRNA is abundantly expressed in 
the placenta as well as in the kidney. OAT4 is the first 
member of the multispecific organic anion transporter 
family that is expressed abundantly in the placenta. 
OAT4 might be responsible for the elimination and 
detoxification of harmful anionic substances from the 
fetus.
5. OAT5
fifth member of OAT (OAT5) was recently identi-
fied by Youngblood and Sweet from mouse kidney12). In 
2001, human OAT5 have reported as hOAT4 by Sun et 
al.49). It was confirmed additionally as a renal steroid 
sulfate conjugate transporter50). The rat ortholog also 
reported in 200551). The mRNA of human, mouse and rat 
OAT5 was detected only kidney. When expressed in 
Xenopus oocytes, mOAT5 mediated the ochratoxin A 
(Km=2.0 µM), estrone sulfate (Km=2.2 µM) and 
dehydroepiandrosterone sulfate (Km=3.8 µM). rOAT5 
also transported those substrate with sodium indepen-
dently. The protein of OAT5 was localized at the apical 
membrane of renal proximal tubules.
　
6. OAT6
The sixth member of OAT was recently identified 
from murine olfactory mucosa13). Based on sequence 
homology proposed to be an organic anion transporter; 
OAT6. However, they did not show any functional 
evidence. In this year, Schnabolk and coworkers have 
reported functional properties of OAT6 using X. laevis 
oocytes and transfected CHO cells52). Transport of 
estrone sulfate by mOat6 was demonstrated to be sa-
turable having Km values of 109.8 µM in oocytes and 
44.8 µM in CHO-mOat6 cells. This mOAT6-mediated 
estrone sulfate uptake was inhibited by 2,4-dichloro-
phenoxyacetate, salicylate, probenecid, and penicillin 
G. Accumulation of estrone sulfate mediated by mOat6 
was significantly trans-stimulated by glutarate indi-
cating that mOAT6 functions as an organic anion/ 
dicarboxylate exchanger.
Functional regulation by caveolin, 
a scaffolding protein
In recent decades, the caveolins have been reported 
as being important modulating molecules that bind to 
some proteins that have biological functions. Caveolins 
are integral membrane proteins that are present in 
caveolae, the small flask-shaped and detergent in-
soluble invaginations in the plasma membrane (Fig. 3), 
and they have been implicated as functioning in the 
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Fig. 4. Western blot analysis using isolated membrane 
fraction and immunoprecipitates by antibodies in the rat 
kidney. A) The kidneys were lysed using a teflon/glass 
homogenizer and a sonicator, and subjected to sucrose 
gradient centrifugation as described under Materials and 
Methods. B) Cell lysates were immuno-precipitated ini-
tially with antibodies of rOAT3 or Cav-1 and the respec-
tive immuno-precipitated proteins were loaded onto each 
lane of a 10% SDS-polyacrylamide gel. Kidney lysate 
was immuno-precipitated initially with rOA3 (left pannel) 
and was immuno-precipitated initially with Cav-1 
antibodies (right pannel). 
[
3
H
]
 e
s
tr
o
n
e
s
u
lf
a
re
u
p
ta
ke
 (
fm
o
l/
o
o
c
y
te
/h
)
0
20
40
60
80
100
120
p<0.01
p<0.05
p<0.01
water rOAT3 XCav1 SODN
(10 pmol)
+ rOAT3
XCav1 AODN 
(10 pmol)
+ rOAT3
XCav1 AODN
(3 pmol)
+ rOAT3
Fig. 5. The effects of Xenopus laevis sense or antisense 
oligodeoxynucleotide on rOAT3-mediated [3H] estrone 
sulfate uptake in Xenopus laevis oocyte expression sys-
tem. Defolliculated stage VI and V oocytes were injected 
water, rOAT3 cRNA (20 ng/oocyte) with/without senese 
or antisense ODN (3 or 10 pmol/oocyte).
vesicular transport processes. Recent studies have 
shown that several transporter proteins including p- 
glycoprotein53), cationic amino acid transporter
54), glu-
cose transporter55), and sodium-calcium exchanger
56) 
are localized in caveolin-enriched lipid raft microdo-
mains and they are regulated by caveolins. The ca-
veolin-binding motif is a protein-protein interaction 
and is composed of eight to nine amino acid residues : 
øXøXXXXø or øXXøXXXXø (where X is any amino acid, 
and ø designates aromatic amino acids like Trp (W), Phe 
(F) or Tyr (Y) and X can be any amino acids). The 
scanning of rOAT1 and rOAT3 amino acid sequence 
showed several caveolin-binding motifs within the 
transmembrane domain or near the intracellular surface 
of the plasma membrane. Recently Kwak et al. have 
reported that rOAT1 and rOAT3 proteins were existed 
in caveolae enriched fraction isolated by sucrose 
gradient ultracentrifugation from rat kidneys57, 58). The 
proteins of OATs and caveolins were co-precipitated 
by each respected antibodies (Fig. 4). When the rOAT1 
and rOAT3 cRNA were expressed with antisense 
oligodeoxynucleotide of caveolins, the transport ability 
of rOAT1 or rOAT3 was decreased (Fig. 5). These 
results show that functional properties was regulated 
by scaffolding protein as well as protein kinase C.
Conclusion
The past few years have witnessed great advances in 
our knowledge of the molecular pharmacology of renal 
organic anion transport. The organic anion transport 
system is also important as a drug or xenobiotics 
transport system. The techniques for molecular biology 
enabled us to obtain much information about the identity 
of the organic anion transporters. The mechanism of 
excretion of organic anions into the primary urine is 
unknown. Understanding the detailed transport 
mechanism and distribution of each transporter in the 
kidney will give us much clues about renal drug 
clearance, drug-drug interaction, drug targeting to the 
kidney, and xenobiotic- or drug- induced nephropathy.
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